1 min read
ORIC Filing Lists -$0.38 Per-Share Loss for June Quarter
The Aug. 3 filing gave the same net loss per share for basic and diluted calculations for the quarter ended June 30, 2026.

ORIC Pharmaceuticals’ quarterly filing dated Aug. 3 lists net loss per share of -$0.38, both basic and diluted, for the quarter ended June 30, 2026.